Published in

Elsevier, Journal of Luminescence, (172), p. 279-285, 2016

DOI: 10.1016/j.jlumin.2015.12.038

Links

Tools

Export citation

Search in Google Scholar

Interaction of 1-Pyrene Sulfonic Acid Sodium Salt with Human Serum Albumin

Journal article published in 2015 by Malgorzata Steblecka, Marian Wolszczak ORCID, Ewa Szajdzinska-Pietek
This paper is available in a repository.
This paper is available in a repository.

Full text: Download

Green circle
Preprint: archiving allowed
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

Steady state and time-resolved techniques of optical spectroscopy were applied to examine the interaction between 1-pyrene sulfonic acid (PSA) sodium salt and human serum albumin (HSA). This work is directed towards finding a convenient fluorescent marker (or blocker) of hydrophobic binding sites within the protein, to be used in the in vitro studies of HSA-drug systems. The observed variation of PSA absorbance with HSA concentration was interpreted in terms of two possible probe/protein binding modes with the binding constants Kb,1=(6.5+/-0.6)∙10^6 M^-1 (a specific receptor site), and Kb,2=(3.8+/-0.8)∙10^5 M^-1 (non-specific binding of up to three probe molecules). The PSA fluorescence is quenched by the albumin (via both static and dynamic mechanisms), and also the HSA-Trp214 fluorescence is quenched by PSA (via resonance energy transfer). These results indicate that the probe is bound in the domain IIA of the secondary HSA structure. At lower [PSA]/[HSA] ratios the PSA fluorescence lifetime is longer than that in homogeneous buffer solutions (not containing HSA). Therefore, we conclude that lower affinity binding sites are distant from the tryptophan residue. This is confirmed by complementary studies on the transient T-T absorbance and on luminescence of the photosensitized singlet oxygen.